Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf348 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Alison Z Swartz und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Vanderbilt University, Nashville, TN 37232, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Body-Weight Trajectory, Weight Gain, Weight Loss. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, CTSA, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Context
Repetitive bouts of weight loss and regain, termed weight cycling, may exaggerate the risk for cardiometabolic disease. We previously identified that weight cyclers were likely to have prescribed medications for hypertension, dyslipidemia, and diabetes—suggesting a high prevalence of cardiometabolic disease.
Objective
No prior study has compared relationships between longitudinal weight trajectory (weight stable, weight gainer, weight loser, or weight cycler) and commonly occurring specific cardiometabolic diseases among persons with similar high baseline body mass index (BMI).
Methods
Using de-identified electronic health record data from all adults treated at Vanderbilt University Medical Center between 1997 to 2020 and a landmark approach, we developed multivariate Cox proportional hazards regression models to determine relationships between weight trajectory and risk for 10 highly prevalent cardiometabolic diseases.
Results
Compared to weight stability, weight cycling associated with an almost 30% increased risk for obstructive sleep apnea [hazard ratio (HR) 1.28; 95% confidence interval (CI) 1.15-1.42], metabolic dysfunction-associated steatotic liver disease (HR 1.28; 95% CI 1.08-1.51), and type 2 diabetes (HR 1.23; 95% CI 1.10-1.38). Weight cycling also associated with a more than 50% increased risk for heart failure (HR 1.54; 95% CI 1.31-1.82), although both weight gain and weight loss also showed increased risk for heart failure (HR 1.29; 95% CI 1.08-1.55 and HR 1.32; 95% CI 1.10-1.58, respectively).
Conclusion
The relationship between weight cycling and cardiometabolic disease risk was independent of having high baseline BMI, which was similar among weight trajectory groups. The present findings support promoting either weight stability at high BMI or weight loss if able to be maintained to prevent the incidence of a variety of cardiometabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Vanderbilt University, Nashville, TN 37232, USA.
- Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN 37212, USA.
ORCID-Profile: Eric Farber-Eger, Heidi J Silver
Förderung
- NCATS NIH HHS
- CTSA
- National Center for Advancing Translational Sciences
Zitieren
APA
Swartz, A. Z., Wood, K., Farber-Eger, E., Petty, A., & Silver, H. J. (2025). Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf348
Vancouver
Swartz AZ, Wood K, Farber-Eger E, Petty A, Silver HJ. Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf348
BibTeX
@article{Swartz2025,
author = {Swartz, Alison Z and Wood, Kathryn and Farber-Eger, Eric and Petty, Alexander and Silver, Heidi J},
title = {Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf348}
}
EUVIMED